entertainment -WSS

entertainment

author：fashion 2025-09-27 21:27:38 - browse：3596

the White House and the lawn in front of it shows behind a railing – coverage from STAT — Mark Wilson/Getty Images

President Biden’s executive order on artificial intelligence amounts to a giant course correction in health care. The actions taken in response could dramatically reshape how AI is used — and how much it costs — in areas from drug research to hospital care.

The order, released in full detail late Monday, calls for two elements of AI oversight that are currently nonexistent in health care: a policy, or independent body, that would test and assure the quality of AI tools, and a “central tracking repository” to report clinical errors associated with the use of the technology.

AI standards bodies in health care have previously pitched both ideas, but throwing the weight of the federal government behind them is more likely to bring them to fruition. Biden’s orders all require action before next fall’s election, a timeline designed to build momentum behind regulations that may be harder for a successor with different ideas to reverse.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Weight loss drug costs may need more research, senator suggests

hotspot

WSS

CRISPR pioneers react to Casgevy, first gene

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Hospitals look to new technology to keep health care workers safe

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Hospitals look to new technology to keep health care workers safe

Data integrity in scientific journals requires "effort" by publishers, institutions

Wikipedia

entertainment

leisure time

The cancer drug shortage isn’t new — and neither are the solutions

Why medical students are struggling with mental health

Heart attack and stroke risk calculators need revising

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

DIEP, the 'gold standard' of breast reconstruction, is under threat

Bird flu: Don't repeat Covid's 'health versus the economy' framing

Activists slam private health insurers over coverage restrictions

World's first CRISPR

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Arc Institute generative AI designs new CRISPR systems

knowledge

Why medical students are struggling with mental health

Childhood cancer progress stalls for Black, Hispanic kids: Report

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Cytokinetics CEO stresses company can launch heart drug on its own

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

explore

hotspot

focus

entertainment